Chapter 4 Coronary artery disease
Punit Ramrakha and
Jonathan Hill
- Atherosclerosis: pathophysiology 112
- Development of atherosclerotic plaques 114
- Epidemiology 116
- Assessment of atherosclerotic risk 118
- Rick factors for CAD 120
- Hypertension 126
- Treatment of high blood pressure 128
- Combining antihypertensive drugs 130
- Lipid management in atherosclerosis 132
- Lipid lowering therapy 136
- When to treat lipids 138
- Diabetes and atherosclerosis 140
- The metabolic syndrome and insulin resistance 144
- Metabolic syndrome: management 148
- Angina pectoris 150
- Acute coronary syndromes 154
- ST elevation myocardial infarction (STEMI) 156
- STEMI: diagnosis 158
- STEMI: general measures 162
- STEMI: repurfusion therapy (thrombolysis) 164
- STEMI: repurfusion by primary PCI 168
- Surgery for acute STEMI 169
- STEMI: additional measures 170
- Right ventricular (RV) infarction 172
- STEMI: predischarge risk stratification 174
- STEMI: complications 176
- Ventricular septal defect post-MI 178
- Acute mitral regurgitation post-MI 180
- Pseudoaneurysm and free wall rupture 180
- Cocaine-induced MI 182
- Ventricular tachyarrhythmias post-MI 184
- Atrial tachyarrhythmia post-MI 184
- Bradyarrhythmias and indications for pacing 186
- Bradyarrhythmias post-MI 186
- Hypotension and shock post-MI 188
- Cardiogenic shock 190
- Non-ST elevation myocardial infarction (NSTEMI)/unstable angina (UA) 192
- NSTEMI/UA: diagnosis 194
- NSTEMI/UA: risk stratificaton 196
- NSTEMI/UA: late risk stratification 198
- NSTEMI/UA: medical management 200
- NSTEMI: invasive vs. non-invasive strategies 204
- Discharge and secondary prevention 204
